Physician profile
Heather J Wheeler
NPI 1801800370
$1,346.17
in general payments reported to CMS, 2019-2025
17 companies · $289 in 2025
The $289 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.99 · 2020: $41.63 · 2021: $148 · 2022: $145 · 2023: $221 · 2024: $488 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $998.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $542.79 | 2021-2025 | Qulipta |
| Lilly USA, LLC | $123.08 | 2021-2025 | Zepbound, Jardiance, Mounjaro |
| Novo Nordisk INC | $105.48 | 2024 | Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $103.50 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $92.49 | 2022-2025 | Farxiga, Airsupra |
| E.R. Squibb & Sons, L.L.C. | $63.71 | 2023-2024 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $61.79 | 2021-2025 | Enflonsia, Capvaxive, Vaxneuvance |
| Pfizer INC. | $57.09 | 2021-2025 | |
| Exact Sciences Corporation | $33.69 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Astellas Pharma US INC | $29.82 | 2024 | Veozah |
| Biohaven Pharmaceutical Holding Company LTD. | $27.00 | 2022 | |
| Allergan, INC. | $23.20 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.12 | 2025 | Jardiance |
| Amgen INC. | $18.43 | 2020 | |
| Janssen Pharmaceuticals, INC | $15.72 | 2024 | Spravato |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $14.60 | 2022 | |
| Nevro Corp. | $11.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Wheeler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.